| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9821 |
| Human Intestinal Absorption | HIA+ | 0.9532 |
| Caco-2 Permeability | Caco2+ | 0.7894 |
| P-glycoprotein Substrate | Non-substrate | 0.7278 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9737 |
| Non-inhibitor | 0.9794 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9278 |
| Distribution |
| Subcellular localization | Plasma membrane | 0.5164 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8124 |
| CYP450 2D6 Substrate | Non-substrate | 0.8920 |
| CYP450 3A4 Substrate | Non-substrate | 0.7109 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.6447 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9160 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9387 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9335 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9778 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9408 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9007 |
| Non-inhibitor | 0.9234 |
| AMES Toxicity | Non AMES toxic | 0.9863 |
| Carcinogens | Carcinogens | 0.5208 |
| Fish Toxicity | High FHMT | 0.8058 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7478 |
| Honey Bee Toxicity | High HBT | 0.6796 |
| Biodegradation | Ready biodegradable | 0.9752 |
| Acute Oral Toxicity | III | 0.8736 |
| Carcinogenicity (Three-class) | Non-required | 0.6618 |